SA
FSUTX logo
Fidelity Select Utilities Growth Portfolio(FSUTX)
Last print 7 weeks agoAbout this dataData status
$126.08▼-1.63 (-1.28%)Stale · 7 weeks old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Fidelity Select Utilities Growth Portfolio (FSUTX)

R&D Expense Growth

0.00%

Fiscal year · Period ending:

FSUTX logo

FSUTX R&D Expense Growth

Latest reported0.00%
FSUTX FY R&D Growth (YoY) (0.00% → 0.00%)
High-resolution chart · PNG

What is r&d expense growth?

Year-over-year research & development expense growth.

FSUTX r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

Fidelity Select Utilities Growth Portfolio R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense GrowthChange
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%—

Frequently asked questions: FSUTX r&d expense growth

What is Fidelity Select Utilities Growth Portfolio (FSUTX)'s current r&d expense growth?

Fidelity Select Utilities Growth Portfolio (FSUTX)'s latest reported r&d expense growth (Fiscal year) is 0.00% as of Dec 31, 2023. Year-over-year research & development expense growth.

How much historical r&d expense growth data is available for FSUTX?

Stock Alarm Pro provides 12 dated annual fiscal periods observations for Fidelity Select Utilities Growth Portfolio (FSUTX)'s r&d expense growth, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare FSUTX's r&d expense growth to peers or set an alert?

You can open FSUTX's r&d expense growth in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on FSUTX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.